Results 81 to 90 of about 764,021 (214)

Growth inhibition and morphologic changes of HeLa cells exposed to unsaturated fatty acid fraction from the liver of x-ray irradiated rabbits (OX) [PDF]

, 1962
Biological effect of the unsaturated fatty acid fraction from the X-ray irradiated rabbit liver (OX) on HeLa cells has been observed in vitro comparing with the effect displayed on the same strain cells by the unsaturated fatty acid fraction from the non-
Seno, Satimaru, Utsumi, Kozo, Yamamoto, Michio   +2 more
core   +1 more source

Carfilzomib activates ER stress and JNK/p38 MAPK signaling to promote apoptosis in hepatocellular carcinoma cells

Acta Biochimica et Biophysica Sinica
Hepatocellular carcinoma (HCC) is one of the most prevalent and deadly cancers in the world, which is frequently diagnosed at a late stage. HCC patients have a poor prognosis due to the lack of an efficacious therapeutic strategy.
Deng Yao, Li Yujie, Yang Mingyue, Gao Yang, Luo Xuling, Chen Hanbin, Guo Meng, Yang Xuefeng, Liu Yongzhang, He Jun, Lu Bin, Liu Naxin   +11 more
doaj   +1 more source

Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease [PDF]

, 2021
Marta Carrillo‐Palau, Alejandro Hernández-Camba, N. Hernandez Alvarez-Buylla, Laura Ramos, Inmaculada Alonso-Abreu, Anjara Hernández-Pérez, Milagros Vela, Laura Arranz, Manuel Hernández‐Guerra, Miguel Á. González‐Gay, Iván Ferraz‐Amaro   +10 more
openalex   +1 more source

An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice. [PDF]

, 2019
Chronic or excess glucocorticoid exposure causes lipid disorders such as hypertriglyceridemia and hepatic steatosis. Angptl4 (angiopoietin-like 4), a primary target gene of the glucocorticoid receptor in hepatocytes and adipocytes, is required for ...
Cheang, Rachel T, Chen, Tzu-Chieh, Fitch, Mark D, Gray, Nora E, Hellerstein, Marc K, Kanamaluru, Deepthi, Lee, Justin Y, Lee, Rebecca A, Tan, Jenna H, Tsai, Sam L, Wang, Jen-Chywan, Yiv, Nicholas   +11 more
core  

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease

Annals of Hepatology
Introduction and Objectives: Fatty liver disease is a multisystem disease. Metabolic dysfunction-associated fatty liver disease (MAFLD) is a more accurate indicator of chronic kidney disease (CKD) than nonalcoholic fatty liver disease (NAFLD).
Ziyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam   +5 more
doaj   +1 more source

Vitamin D to reduce liver fibrosis in non-alcoholic fatty liver disease [PDF]

, 2017
BACKGROUND: As the prevalence of metabolic risk factors in the American population has increased over time, so too has the diagnoses of non-alcoholic fatty liver disease (NAFLD).
Fox, Ryan
core  

Liver disease, the Swiss army knife of comorbidity: A patient perspective from the grass roots

Endocrinology, Diabetes & Metabolism, 2020
Wayne Eskridge
doaj   +1 more source

Efficacy and safety of electroacupuncture for metabolic dysfunction-associated fatty liver disease: a study protocol for a multicentre, randomised, sham acupuncture-controlled, patient-blinded clinical trial

BMJ Open
Background Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common chronic liver disease in the world and carries an increased risk of liver-related events, but no approved medicine.
Hao Ren, Wei Chen, Lei Yang, Xinyu Zhao, Di Cao, Qianyi Wang, Jingjie Zhao, Jing-Wen Yang, Hong You, Xiangdong Hu   +9 more
doaj   +1 more source

Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide

Kaohsiung Journal of Medical Sciences
With the introduction of direct‐acting antivirals, elimination of hepatitis C virus (HCV) infection is becoming possible. People who inject drugs (PWID) represent a population with a high risk for HCV infection, which has been reported as high as 90% in ...
Chi‐Ming Tai, Ming‐Lung Yu
doaj   +1 more source

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors [PDF]

, 2009
Anna Kotronen, Markku Peltonen, Antti Hakkarainen, Ksenia Sevastianova, Robert Bergholm, Lina Johansson, Nina Lundbom, Aila Rissanen, Martin Ridderstråle, Leif Groop, Marju Orho‐Melander, Hannele Yki‐Järvinen   +11 more
openalex   +1 more source